CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Open-market sale Director sold 964 shares at $23.89 ($23,033)
- 4 Open-market sale Director sold 964 shares at $23.89 ($23,027)
- 4 Open-market sale Director sold 964 shares at $23.89 ($23,025)
- 4 Grant or award Director acquired 4,053 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 3,324 shares at an average $16.02 ($53,253)
- 4 Open-market sale EVP, Pres., Novocure Oncology sold 2,519 shares at an average $16.02 ($40,358)
- 4 Grant or award Chief Financial Officer acquired 102,249 shares (grant or award)
- 4 Open-market sale EVP, Pres., Novocure Oncology sold 2,078 shares at $16.14 ($33,545)
- 4 Grant or award Chief Human Resources Officer acquired 71,574 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 81,799 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 51,124 shares (grant or award)
- 4 Grant or award Chief Science Officer acquired 51,124 shares (grant or award)
- 4 Grant or award General Counsel acquired 81,927 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 2,303 shares at $16.14 ($37,177)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Growth Officer sold 382 shares at $12.65 ($4,832)
- 4 Grant or award Chief Human Resources Officer acquired 37,593 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 7 of 39 · 780 filings